NIH study shows vaccines provide extremely limited protection against ‘long COVID’

(TRENDING POLITICS) – “Long Covid” has long been the media’s justification for people to get vaccinated for Covid-19, regardless of prior infection to the virus. However, a recent longitudinal study by the National Institute of Health has thrown into question whether vaccines have strong efficacy against “long Covid.”

As explained in Nature Medicine, post-acute sequelae of Covid-19 or PASC, also called “long COVID,” is “an umbrella term used to describe chronic outcomes of SARS-CoV-2 infection.” It states that a “prominent subset of patients with PASC includes those who experience a syndrome characterized by unexplained exertion intolerance, debilitating fatigue, cognitive and sensory disturbances, headaches, myalgia, and recurrent flu-like symptoms.” Covid-19 is not unique in triggering such lingering debilitating symptoms, the authors point out.

On Wednesday, Nature Medicine published a new report that shows vaccination does not appear to provide nearly the amount of protection against “long Covid” as was previously claimed.

Read the full story ›

The post NIH study shows vaccines provide extremely limited protection against 'long COVID' appeared first on WND.

by is licensed under